Panagora Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Sell |
47,190
-31
| -0.1% | -$1.03K | 0.01% | 533 |
|
|
2025
Q1 | $1.38M | Hold |
47,221
| – | – | 0.01% | 603 |
|
|
2024
Q4 | $1.55M | Sell |
47,221
-20,764
| -31% | -$682K | 0.01% | 569 |
|
|
2024
Q3 | $3.02M | Sell |
67,985
-106,885
| -61% | -$4.75M | 0.01% | 449 |
|
|
2024
Q2 | $7.54M | Buy |
+174,870
| New | +$7.54M | 0.04% | 258 |
|
|
2023
Q2 | – | Sell |
-20,052
| Closed | -$461K | – | 1244 |
|
|
2023
Q1 | $461K | Hold |
20,052
| – | – | ﹤0.01% | 1149 |
|
|
2022
Q4 | $563K | Sell |
20,052
-4,818
| -19% | -$135K | ﹤0.01% | 1116 |
|
|
2022
Q3 | $703K | Buy |
+24,870
| New | +$703K | ﹤0.01% | 1009 |
|
|
2021
Q3 | – | Sell |
-3,208
| Closed | -$177K | – | 1714 |
|
|
2021
Q2 | $177K | Buy |
3,208
+33
| +1% | +$1.82K | ﹤0.01% | 1689 |
|
|
2021
Q1 | $164K | Buy |
3,175
+2,366
| +292% | +$122K | ﹤0.01% | 1769 |
|
|
2020
Q4 | $35K | Hold |
809
| – | – | ﹤0.01% | 2103 |
|
|
2020
Q3 | $28K | Hold |
809
| – | – | ﹤0.01% | 2128 |
|
|
2020
Q2 | $43K | Hold |
809
| – | – | ﹤0.01% | 2012 |
|
|
2020
Q1 | $29K | Buy |
+809
| New | +$29K | ﹤0.01% | 1983 |
|
|
2016
Q4 | – | Sell |
-10,510
| Closed | -$555K | – | 2362 |
|
|
2016
Q3 | $555K | Hold |
10,510
| – | – | ﹤0.01% | 1411 |
|
|
2016
Q2 | $440K | Sell |
10,510
-4,843
| -32% | -$203K | ﹤0.01% | 1410 |
|
|
2016
Q1 | $623K | Buy |
15,353
+14,865
| +3,046% | +$603K | ﹤0.01% | 1284 |
|
|
2015
Q4 | $32K | Buy |
+488
| New | +$32K | ﹤0.01% | 2079 |
|
|
2015
Q2 | – | Sell |
-521
| Closed | -$49K | – | 2417 |
|
|
2015
Q1 | $49K | Buy |
+521
| New | +$49K | ﹤0.01% | 2095 |
|
|
2014
Q2 | – | Sell |
-62
| Closed | -$2K | – | 2314 |
|
|
2014
Q1 | $2K | Buy |
+62
| New | +$2K | ﹤0.01% | 2309 |
|